2024 Igor Tulchinsky – PCF VAlor Challenge Award Germline Genomic and Clinical Predictors of Prostate Cancer Outcomes and Treatment Toxicity in the ProtecT Randomized Trial Principal Investigators: Tyler Seibert, MD,…
… Investigators: James Kelly, PhD (Weill Cornell Medicine), David Rickman, PhD (Weill Cornell Medicine), Joseph Osborne, MD, PhD (Weill Cornell Medicine), Edward Fung, PhD (Weill Cornell Medicine), Juan Miguel Mosquera,…
… More 2019 PCF Challenge Award Discovering drivers of treatment response and resistance in the multi-focal prostate tumor microenvironment Principal Investigators: Joshua Lang, MD, MSc (University of Wisconsin), Steve Cho,…
… Investigators: Arianna Calcinotto, PhD (Institute of Oncology Research), Adam Sharp, MD, PhD (The Institute of Cancer Research and The Royal Marsden Hospital), Antje Neeb, PhD (The Institute of Cancer…
… Chao Lu, PhD (Columbia University Medical Center) Learn More 2023 Bayer-PCF Darolutamide Challenge Award Darostep: Evaluating Step Counts as a Biomarker and its Relationship on Treatment Outcomes in Vulnerable…
… 2023 Durden Foundation-PCF Challenge Award Characterizing Imaging, Genomic and Immune Predictors of 177Lu-PSMA (Lu-PSMA) and Olaparib Response in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) Principal Investigators: Shahneen…
2023 PCF Challenge Award Identifying Drivers of Aggressive Prostate Cancer and Racial Disparities in Patients Presenting with Low-Grade Disease Principal Investigators: Vanessa Hayes, PhD(The University of Sydney),Gail Prins, PhD (University…
… a decade. We thank all of the award recipients and applicants – past and present – who have dedicated themselves to finding new ways to fight this deadly disease,…
… Johns Hopkins School of Medicine), Emma Hammarlund, PhD (Lund University) Young Investigators: George Butler, PhD (Johns Hopkins School of Medicine), Christopher Carroll, PhD (Lund University), Bryan Lee, PhD (Johns…
… may be useful as prognostic markers that can be incorporated into clinical risk stratification models, to improve personalized therapy recommendations in patients with newly diagnosed, localized prostate cancer. In…
